References
- Lorentzen B, Birkeland KI, Endressen MJ, et al. Glucose intolerance in women in pre-eclampsia. Acta Obstet Gynecol Scand 1998;77:22–7
- Martinez AE, Gonzalez OM, Quinones GA, et al. Hyperinsulinaemia in glucose intolerant women with pre-eclampsia. A case controlled study. AmJ Hypertens 1996;9:610–14
- Nisell H, Erikssen C, Persson B, et al. Is carbohydrate metabolism altered among women who have under-gone pre-eclamptic pregnancy? Gynecol Obstet Inv 1999;48: 241–6
- Kaaja R, Laivuori H, Laakso M, et al. Evidence of a state of increased insulin resistance in pre-eclampsia. Metabolism 1999;48 892–6
- Laivuori H, Tikkanen MJ, Ylikorkala O. Hyper-insulinaemia 17 years after pre-eclamptic first pregnancy. J Clin Endocrin Metabol 1996;81: 2908–11
- Fuh MM, Yin CS, Pei D, et al. Resistance to insulin-mediated glucose uptake and hyperinsulin-aemia in women who had pre-eclampsia during pregnancy. Am J Hypertens 1995;8:768–71
- Chen CH, Lin KC, Tsai ST, et al. Different associa-tion of hypertension and insulin related metabolic syndrome between men and women in 8437 non-diabetic Chinese. Am J Hypertens 2000;13:846–53
- Thomas GN, Tomlinson B, Chan JC, et al. An insulin receptor gene polymorphism is associated with diastolic blood pressure in Chinese subjects with components of the metabolic syndrome. Am J Hypertens 2000;13:745–52
- Sowers JR, Saleh AA, Sokol RJ. Hyperinsulinemia and insulin resistance are associated with pre-eclampsia in African-Americans. Am J Hypertens 1995;8:1–4
- Gans RO, Kraayenbrink AA, Van Geijn HP, et al. Insulin resistance characterises pregnant women that will develop pre-eclampsia. Presented at the meeting of the American Society of Hypertension XI, 1996;9(4): C 14 (Abstract)
- Visser W, Beckmann I, Lim HL, et al. Bioactive tumour necrosis factor a in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol 1994;101:1081–2
- Vince GL, Starkey PM, Ausrgulen R, et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995;102:20–5
- Uysal KT, Wiesbrock SM, Marino MW, et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997;389: 610–14
- Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metabol 2000;11:212–17
- Katsuki A, Sumida Y, Murashima S, etal. Serum levels of tumour necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Gun Endocrinol Metabol 1998;83:859–62
- Bertin E, Nguyen P, Guenonou M, etal. Plasma levels of tumour necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metabol 2000;26:178–82
- Anim-Nyame N, Sooranna PJ, Johnson MR, et al. Longitudinal study of resting peripheral blood flow in normal pregnancy and pregnancies complicated by chronic hypertension and pre-eclampsia. Cardiovasc Res 2001;50:603–9
- National High Blood Pressure Educational Programme Working group on High Blood Pressure in Pregnancy. Report. Am J Obstet Gynecol 2000; 183:S1–S22
- Watanabe N, Kamel S, Ohkubo A, et al. Urinary protein as measured with pyrogallol red-molybdate complex manually and in Hitachi 726 automated analyser. Clin Chem 1986;32:1551–4
- Duncan MH, Singh BM, Wise PH, et al. A simple measure ofinsulin resistance. Lancet 346:1995;120–21
- Cleland SJ, Petrie JR, Morris AD, etal. FIRI: a fair insulin resistance index? Lancet 1996;347:770
- Matthews DR, Hosker JP, Rudenski JS, et al. Homeostasis model assessment: insulin resistance and J3-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19
- Bergman RN, Prager R, Volund A, etal. Equivalence of insulin sensitivity index in man derived by the minimal model method and euglycaemic glucose clamp. J Clin Invest 1987;79:790–800
- Del Prato S, Pozzilli P. FIRI: fasting or false insulin resistance index? Lancet 1996;347:132
- Catalano PM, Tyzbir ED, Roman NM, et al. Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. AmJ Obstet Gynecol 1991;165:1667–72
- Cousins L. Insulin sensitivity in pregnancy. Diabetes 1991;40 (Suppl 2):39–43
- Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-a is a predictor of insulin resistance in human pregnancy. Diabetes 2002.51:2207–13
- Rowe JW, Young JB, Minaker KL, et al. Effect of insulin and glucose infusion on sympathetic nervous system activity in normal man. Diabetes 1981; 30:219–25
- Redman CW, Sacks GP, Sargent IL. Pre-eclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499–506
- Serin YS, Ozcelik B, Bapbuo M, et al. Predictive value of tumor necrosis factor alpha in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2002;100:143–5
- Bulb M, Garcia-Lorda P, Peinado-Onsurbe J, et al. TNF-alpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipose LPL activity and leptin synthesis. Int J Obes Relat Metab Disord 2002;26:652–8
- Baron AD, Laakso M, Brechtel G, etal. Mechanism of insulin resistance in IDDM: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metabol 1991;73:637–43
- Anim-Nyame N, Sooranna SR, Johnson MR, et al. Resting peripheral blood flow in normal pregnancy and pre-eclampsia. Clin Sci 2000;99:505–10
- Lorentzen B, Endresen MJ, Clausen T, et al. Fasting serum free fatty acid and triglycerides are increased before 20 weeks gestation in women who later develop pre-eclampsia. Hypertens Pregnancy 1994;13: 103–9
- Lorentzen B, Drevon CA, Endresen MJ, et al. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and pre-eclamptic pregnancies. BrJ Obstet Gynaecol 1995;102:530–7
- Roberts JM, Taylor RN, Musci TJ, et al. Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200–4
- Laight DW, Carrier MJ, Anggard EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 2000;47:457–64
- Pelikánova T, Kohout M, Val& J, et al. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism 1989;38:188–92
- Giudice LC, Martina NA, Crystal RA, et al. I. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe pre-eclampsia. Am J Obstet Gynecol 1997;176,751–7
- Lewitt MS, Baxter RC. Insulin-like growth factor binding protein-1: a role for glucose counter regulation? Mot Cell Endocrinol 1991;79:C147–52
- Lewitt MS, Denyer GS, Cooney GJ, etal. Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 1991;129:2254–6